Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Hormone replacement therapy refers to the treatment of the patients with growth hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low.
Hormonal imbalance disorders, with an increase in the geriatric population, is one of the major factors responsible for the growth of this market. The risk of cancer associated with the HRT certainly restricts the growth of this market. The combination HRT increases the risk of breast cancer by nearly 70%, even when used for a short period of time. The Cancer Research UK has shown in past that HRT increases the risk for several types of cancers, including uterus and ovarian cancers. The United States is expected to have the largest market share in the forecast period. Growing geriatric population is one of the primary factors for the growth of the market.
In 2018, the global Hormone Replacement Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hormone Replacement Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hormone Replacement Therapy development in United States, Europe and China.
The key players covered in this study
F. Hoffmann-La Roche
Novartis
Novo Nordisk
Amgen
ANI Pharmaceuticals
Bayer
Eli Lilly
Hisamitsu Pharmaceutical
Ipsen
Merck
Mylan Laboratories
Orion
QuatRx Pharmaceuticals
Teva Pharmaceutical Industries
TherapeuticsMD
Market segment by Type, the product can be split into
Estrogen Replacement Therapy
Growth Hormone Replacement Therapy
Market segment by Application, split into
Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hormone Replacement Therapy status, future forecast, growth opportunity, key market and key players.
To present the Hormone Replacement Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hormone Replacement Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Hormonal imbalance disorders, with an increase in the geriatric population, is one of the major factors responsible for the growth of this market. The risk of cancer associated with the HRT certainly restricts the growth of this market. The combination HRT increases the risk of breast cancer by nearly 70%, even when used for a short period of time. The Cancer Research UK has shown in past that HRT increases the risk for several types of cancers, including uterus and ovarian cancers. The United States is expected to have the largest market share in the forecast period. Growing geriatric population is one of the primary factors for the growth of the market.
In 2018, the global Hormone Replacement Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hormone Replacement Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hormone Replacement Therapy development in United States, Europe and China.
The key players covered in this study
F. Hoffmann-La Roche
Novartis
Novo Nordisk
Amgen
ANI Pharmaceuticals
Bayer
Eli Lilly
Hisamitsu Pharmaceutical
Ipsen
Merck
Mylan Laboratories
Orion
QuatRx Pharmaceuticals
Teva Pharmaceutical Industries
TherapeuticsMD
Market segment by Type, the product can be split into
Estrogen Replacement Therapy
Growth Hormone Replacement Therapy
Market segment by Application, split into
Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hormone Replacement Therapy status, future forecast, growth opportunity, key market and key players.
To present the Hormone Replacement Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hormone Replacement Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
